FindTrial
Sign In

To identify hyperglycemia in normal subject

To identify anytime hyperglycaemia in subjects with nor glycaemia and prediabetes. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055484
Enrollment
50
Registered
2023-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

National Diabetes Obesity and Cholesterol Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age -30-60 yrs 2.BMI- >23- 35Kg/m2

Exclusion criteria

Exclusion criteria: 1.Hypothyroidism on treatment. 2.Substantial alcohol consumption ( >20 g/day for women or >30 g/day for men). 3.Current smoker 4.Concomitant confounding drug use (steroid, vit E)

Design outcomes

Primary

MeasureTime frame
To identify anytime hyperglycaemia in subjects with normoglycaemia & prediabetes.Timepoint: 12 months—

Secondary

MeasureTime frame
1.To assess glycaemic variability in patients diagnosed as normoglycaemia by HbA1c & oral glucose tolerance test. 2. To correlate basal and postprandial hyperglycaemia as assessed by CGMS with HbA1c and fasting blood glucose.Timepoint: 12 months—

Countries

India

Contacts

Public ContactAnoop Misra

Fortis CDOC Hospital

anoopmisra@gmail.com01149101222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026